A Study of the Absorption, Metabolism and Excretion of [14C]XZP-3621 in Human
Clinical trial NCT05836805 · UNKNOWN
Trial details
- NCT number
- NCT05836805
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2023-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.